Life Extension Blood Test Super Sale

Daily News: Disease

AHF: Gilead Outrage on Hep C Drug Price!

Business Wire


$84,000 for a twelve week supply of Sovaldi, Gilead's new Hepatitis C drug, (sofosbuvir), which was approved Friday by the F.D.A.--$1,000 a pill!

Drug is only one portion of a two drug, twelve-week combination treatment for hepatitis; Gilead's predatory history of price gouging on lifesaving medications sets stage for action from government officials and drug purchasers for government programs to compel Gilead to cut pricing.

WASHINGTON--(BUSINESS WIRE)-- AIDS Healthcare Foundation (AHF), the nation's largest HIV/AIDS nonprofit medical provider, expressed its profound outrage at Gilead Sciences over the price of Sovaldi, its new Hepatitis C drug, which was approved by the Food and Drug Administration (FDA) on Friday. Gilead set the price at $84,000 Wholesale Acquisition Cost (WAC) for a twelve-week supply of the drug--$1,000 per pill. The drug, known during drug trials as GS-7977 (sofosbuvir), is one component of a two-drug, twelve-week combination treatment for Hepatitis C, which affects an estimated 3.2 million people in the United States.

"For Gilead, we have outrage, pure and simple," said Michael Weinstein, President of AIDS Healthcare Foundation. "There can be no better example of the unbridled greed of the pharmaceutical industry than Gilead's latest move: pricing its new hepatitis drug at $84,000 per 28-tablet bottle or $1,000 per pill! Gilead's predatory pricing of Sovaldi is a direct threat to public heath, and it sets the stage for legislators and advocates to demand that officials who purchase drugs for government programs like Medicaid, Medicare and the AIDS Drug Assistance Programs act decisively to rein in pricing and protect patient access to lifesaving medications."

MEDIA AVAILABILITY: AHF to comment on FDA approval, and Gilead's pricing, of its new Hepatitis C drug, Sovaldi (sofosbuvir).

WHO: Michael Weinstein, President, AIDS Healthcare Foundation

CONTACT: Ged Kenslea, AHF Communications +1.323.791.5526 mobile

AIDS Healthcare Foundation (AHF), the largest global AIDS organization, currently provides medical care and/or services to more than 260,000 individuals in 32 countries worldwide in the US, Africa, Latin America/Caribbean, the Asia/Pacific Region and Eastern Europe. To learn more about AHF, please visit our website:, find us on Facebook: and follow us on Twitter: @aidshealthcare

AIDS Healthcare Foundation Ged Kenslea Communications Director Work: 323-308-1833 Cell: 323-791-5526 or Tom Myers General Counsel & Chief of Public Affairs Work: 323-860-5259

Source: AIDS Healthcare Foundation

Copyright Business Wire 2013

Articles featured in Life Extension Daily News are derived from a variety of news sources and are provided as a service by Life Extension. These articles, while of potential interest to readers of Life Extension Daily News, do not necessarily represent the opinions nor constitute the advice of Life Extension.

  • Consumer Alerts | Learn about issues that could impact your right to obtain the nutritional supplements and/or hormones such as DHEA that you depend on.

  • LEF Forum | Life Extension hosts Forums on Supplements, Hormones, Lifestyles, Disorders/Diseases, and other areas of interest to life extensionists worldwide.

  • What's Hot | News flashes are posted here frequently to keep you up-to-date with the latest advances in health care, nutritional supplements, and longevity.

  • Legislative Action Center | Take action on important current issues featured in Life Extension magazine and our web site.

  • Events | Find out about upcoming life extension related conferences, seminars, and meetings, or view reports on past events.

  • Life Extension Update | Our periodical newsletter reports new findings in longevity, preventive medicine and disease as soon as they are discovered!

  • Multimedia Center | An information-packed collection of video and audio featuring various health topics of importance to you.

Top 12 Steps For Achieving Ultimate Health